SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐
Check the appropriate box:
|☐||Preliminary Proxy Statement|
|☐||Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))|
|☐||Definitive Proxy Statement|
|☒||Definitive Additional Materials|
|☐||Soliciting Material under §240.14a-12|
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|☒||No fee required.|
|☐||Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.|
Title of each class of securities to which transaction applies:
Aggregate number of securities to which transaction applies:
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
Proposed maximum aggregate value of transaction:
Total fee paid:
|☐||Fee paid previously with preliminary materials.|
|☐||Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.|
Amount Previously Paid:
Form, Schedule or Registration Statement No.:
June 1, 2018
You have previously received proxy materials in connection with Analogics Special Meeting of Shareholders to be held on June 21, 2018 in which you are being asked to approve a merger with an affiliate of Altaris Capital Partners. According to our latest records, your vote for this meeting has not yet been received. Your vote is very important.
The Analogic Board of Directors believes this transaction is in the best interests of all shareholders and unanimously recommends that you vote FOR the transaction. It is the result of a 10-month, strategic alternatives review that considered a comprehensive range of alternatives, including the sale of the entire company, separating the Companys three business units, and the continued short- and long-term operation of the Company on a stand-alone basis. The process involved direct outreach to potential financial and strategic buyers as well as responses to inbound expressions of interest and ultimately included contact with 75 parties. The transaction presents the best combination of certainty and value for stockholders and is a 25% premium to Analogics closing share price of $67.45 on June 7, 2017, the day after the Company reported quarterly earnings for the third quarter of fiscal 2017 and announced the launch of the review process. Further reasons for the transaction can be found in the proxy statement.
To ensure your representation at the Analogic Special Meeting of Shareholders, please complete and return the enclosed proxy card or submit your proxy by telephone using the toll-free number noted on the proxy card or over the Internet at the website noted on the proxy card. If you hold your shares at a bank or brokerage firm, your bank or broker cannot vote your shares without your specific instructions.
If you have any questions or need assistance submitting a proxy to have your shares of Company common stock voted at the special meeting, please call Georgeson LLC, the companys proxy solicitor, toll-free at (866) 431-2105.
On behalf of the Analogic Board of Directors and management team, thank you for your continued support.
Very truly yours,
|Bernard C. Bailey||Fred B. Parks|
|Chairman of the Board||Chief Executive Officer|
Additional Information and Where to Find It
Analogic filed a definitive proxy statement with the SEC in connection with the transaction (the Proxy Statement), including a form of proxy card, on May 16, 2018. The Proxy Statement and form of proxy card have been mailed to Analogics shareholders. The Proxy Statement contains important information about Altaris, Analogic, the merger and related matters. Investors and security holders are urged to read the Proxy Statement carefully.
Investors and security holders can obtain free copies of the Proxy Statement and other documents filed with the SEC by Analogic through the web site maintained by the SEC at www.sec.gov. In addition, investors and security holders can obtain free copies of the Proxy Statement from Analogic by contacting Analogics Investor Relations department at email@example.com or by calling 978-326-4058.
Analogic and its directors and executive officers may be deemed to be participants in the solicitation of proxies in respect to the transactions contemplated by the merger agreement. Information regarding Analogics directors and executive officers, including the direct and indirect interests of Analogics directors and executive officers in the merger, is contained in the Analogics Annual Report on Form 10-K for the year ended July 31, 2017, its proxy statement dated November 2, 2017 and in the Proxy Statement dated May 16, 2018, each of which is filed with the SEC. These documents can be obtained free of charge from the sources listed above.
Safe Harbor for Forward-Looking Statements
Statements in this document regarding the proposed transaction between Altaris and Analogic, the expected timetable for completing the transaction, future financial and operating results, benefits and synergies of the transaction, future opportunities for the combined company and any other statements about future expectations, plans, and prospects for Analogic, including statements containing the words believes, anticipates, plans, expects, and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the risk that the proposed merger may not be completed in a timely manner, or at all, which may adversely affect Analogics business and the price of its common stock; the failure to satisfy all of the closing conditions of the proposed merger, including the approval of the merger agreement by Analogics stockholders; the occurrence of any event, change or other circumstance that could give rise to the termination of the merger agreement; the effect of the announcement or pendency of the proposed merger on Analogics business, operating results, and relationships with customers, suppliers, competitors and others; risks that the proposed merger may disrupt Analogics current plans and business operations; potential difficulties retaining employees as a result of the proposed merger; risks related to the diverting of managements attention from Analogics ongoing business operations; the outcome of any legal proceedings that may be instituted against Analogic related to the merger agreement or the proposed merger; risks relating to product development and commercialization, limited demand for Analogics products or the limited number of customers for such product; risks associated with competition; uncertainties associated with regulatory agency approvals; competitive pricing pressures; downturns in the economy; the risk of potential intellectual property litigation; acquisition related risks; and other factors discussed in Analogics most recent quarterly and annual reports filed with the SEC. In addition, the forward-looking statements included in this document represent Analogics views as of the date of this document. While Analogic anticipates that subsequent events and developments will cause Analogics views to change, Analogic specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing Analogics views as of any later date.